The importance of polymeric and non-polymeric Oxaliplatin (OXA) nanomedicine in cancer
therapy takes center stage in this article. OXA, a chemotherapy agent deployed in the …

Background: This systematic review and meta-analysis aimed to determine whether
chemotherapy-induced peripheral neuropathy (CIPN) affects the risk of falls and physical …

Chronic pain is a major burden for the society and remains more prevalent and severe in
females. The presence of chronic pain is linked to persistent alterations in the peripheral and …

Purpose This study aims to evaluate the efficacy and safety of laser photobiomodulation
(PBM) for treatment of established chemotherapy-induced peripheral neuropathy (CIPN) in …

Background: Chemotherapy-induced peripheral neuropathy (CIPN) is a painful condition,
experienced by patients undergoing chemotherapy with some specific drugs, such as …

Clinicians should be aware of the potential for persistent TIPN and its impact on patients'
function and QOL. Future research should focus on large prospective studies with systematic …

Background Colorectal cancer is diagnosed in approximately 500,000 patients each year in
Europe, leading to a high number of patients having to cope with the consequences of …

Non-pharmacological self-management interventions for chemotherapy-induced peripheral
neurotherapy (CIPN) are of clinical interest; however, no systematic review has synthesized …

Development of painful oxaliplatin-induced peripheral neuropathy (OIPN) is a major
problem in people who receive oxaliplatin as part of cancer treatment. The pain experienced …

Background Colorectal cancer remains the second leading cause of cancer death in North
America. Fluorouracil and oxaliplatin based adjuvant chemotherapy for resected colon …